JoVE Logo
Faculty Resource Center

Sign In

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

DOI :

10.3791/56084-v

October 15th, 2017

October 15th, 2017

8,106 Views

1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 2Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University

Ivacaftor and ivacaftor-lumacaftor combination are two new CF drugs. However, there is still a dearth of understanding on their PK/PD and pharmacology. We present an optimized HPLC-MS technique for the simultaneous analysis of ivacaftor and its major metabolites, and lumacaftor.

Tags

LC MS MS Method

-- Views

Related Videos

article

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

article

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

article

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

article

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

article

Sampling Strategies and Processing of Biobank Tissue Samples from Porcine Biomedical Models

article

Collecting Hair Samples for Hair Cortisol Analysis in African Americans

article

High-Throughput Analysis of Optical Mapping Data Using ElectroMap

article

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

article

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

article

Culture and Imaging of Human Nasal Epithelial Organoids

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved